Reduction of myocardial cyclic GMP content as a possible mechanism for protection of the hypoxic heart by methylprednisolone (MP)

W. J. George, R. W. Busuttil, L. J. Ignarro

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)No.512
JournalPharmacologist
Volume17
Issue number2
StatePublished - 1975

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this